110 related articles for article (PubMed ID: 18700620)
1. Role of PGL-I of M. leprae in TNF-alpha production by in vitro whole blood assay.
Dhungel S; Ranjit C; Sapkota BR; Macdonald M
Nepal Med Coll J; 2008 Mar; 10(1):1-3. PubMed ID: 18700620
[TBL] [Abstract][Full Text] [Related]
2. Effect of unique Mycobacterium leprae phenolic glycolipid-I (PGL-I) on tumour necrosis factor production by human mononuclear cells.
Charlab R; Sarno EN; Chatterjee D; Pessolani MC
Lepr Rev; 2001 Mar; 72(1):63-9. PubMed ID: 11355520
[TBL] [Abstract][Full Text] [Related]
3. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
[TBL] [Abstract][Full Text] [Related]
6. Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae.
Vachula M; Holzer TJ; Andersen BR
J Immunol; 1989 Mar; 142(5):1696-701. PubMed ID: 2537362
[TBL] [Abstract][Full Text] [Related]
7. Detection of IgA anti-PGL-I specific antigen to Mycobacterium leprae in mangabey monkeys inoculated with M. leprae.
Saad MH; Gormus BJ; Cho SN; Bernheimer H; Schwerer B
Lepr Rev; 1995 Dec; 66(4):296-306. PubMed ID: 8637383
[TBL] [Abstract][Full Text] [Related]
8. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
[TBL] [Abstract][Full Text] [Related]
9. T cell-monocyte contact enhances tumor necrosis factor-alpha production in response to Mycobacterium leprae.
Sampaio EP; Oliveira RB; Warwick-Davies J; Neto RB; Griffin GE; Shattock RJ
J Infect Dis; 2000 Nov; 182(5):1463-72. PubMed ID: 11023469
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of Mycobacterium leprae-specific phenolic glycolipid (PGL-I) antigen in human leprosy lesions and in M. leprae isolated from armadillo liver.
Boddingius J; Dijkman H
J Gen Microbiol; 1990 Oct; 136(10):2001-12. PubMed ID: 2269873
[TBL] [Abstract][Full Text] [Related]
11. Immuno-histopathology in the diagnosis of early leprosy.
Weng XM; Chen SY; Ran SP; Zhang CH; Li HY
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):426-33. PubMed ID: 11332285
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mycobacterium leprae's phenolic glycolipid-I on interferon-gamma augmentation of monocyte oxidative responses.
Vachula M; Holzer TJ; Kizlaitis L; Andersen BR
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):342-6. PubMed ID: 2165510
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium leprae in neurons of the medulla oblongata and spinal cord in leprosy.
Aung T; Kitajima S; Nomoto M; En J; Yonezawa S; Arikawa I; Goto M
J Neuropathol Exp Neurol; 2007 Apr; 66(4):284-94. PubMed ID: 17413319
[TBL] [Abstract][Full Text] [Related]
14. Anti-PGL-1 antibody levels in Thai leprosy patients.
Kampirapap K; Singtham N
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):728-33. PubMed ID: 9253875
[TBL] [Abstract][Full Text] [Related]
15. Identification of trehalose dimycolate (cord factor) in Mycobacterium leprae.
Kai M; Fujita Y; Maeda Y; Nakata N; Izumi S; Yano I; Makino M
FEBS Lett; 2007 Jul; 581(18):3345-50. PubMed ID: 17601578
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
[TBL] [Abstract][Full Text] [Related]
17. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
Tadesse A; Taye E; Sandoval F; Shannon EJ
Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
[TBL] [Abstract][Full Text] [Related]
19. Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae.
Ramanathan VD; Parkash O; Tyagi P; Sengupta U; Ramu G
Microb Pathog; 1990 Jun; 8(6):403-10. PubMed ID: 2266854
[TBL] [Abstract][Full Text] [Related]
20. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.
Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F
Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
